当前位置: 首页 SCI期刊 SCIE期刊 医学 中科院3区 JCRQ2 期刊介绍(非官网)
Complementary Therapies In Clinical Practice

Complementary Therapies In Clinical PracticeSCIE

国际简称:COMPLEMENT THER CLIN  参考译名:临床实践中的补充疗法

  • 中科院分区

    3区

  • CiteScore分区

    Q1

  • JCR分区

    Q2

基本信息:
ISSN:1744-3881
E-ISSN:1873-6947
是否OA:未开放
是否预警:否
TOP期刊:否
出版信息:
出版地区:NETHERLANDS
出版商:Churchill Livingstone
出版语言:English
出版周期:4 issues/year
出版年份:1995
研究方向:INTEGRATIVE & COMPLEMENTARY MEDICINE
评价信息:
影响因子:2.2
H-index:43
CiteScore指数:6.3
SJR指数:0.71
SNIP指数:1.035
发文数据:
Gold OA文章占比:15.63%
研究类文章占比:68.18%
年发文量:66
自引率:0.0666...
开源占比:0.1042
出版撤稿占比:0
出版国人文章占比:0.12
OA被引用占比:0.0410...
英文简介 期刊介绍 CiteScore数据 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Complementary Therapies In Clinical Practice期刊介绍

Complementary Therapies in Clinical Practice is an internationally refereed journal published to meet the broad ranging needs of the healthcare profession in the effective and professional integration of complementary therapies within clinical practice.

Complementary Therapies in Clinical Practice aims to provide rigorous peer reviewed papers addressing research, implementation of complementary therapies (CTs) in the clinical setting, legal and ethical concerns, evaluative accounts of therapy in practice, philosophical analysis of emergent social trends in CTs, excellence in clinical judgement, best practice, problem management, therapy information, policy development and management of change in order to promote safe and efficacious clinical practice.

Complementary Therapies in Clinical Practice welcomes and considers accounts of reflective practice.

期刊简介Complementary Therapies In Clinical Practice期刊介绍

《Complementary Therapies In Clinical Practice》自1995出版以来,是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

Cite Score数据(2024年最新版)Complementary Therapies In Clinical Practice Cite Score数据

  • CiteScore:6.3
  • SJR:0.71
  • SNIP:1.035
学科类别 分区 排名 百分位
大类:Medicine 小类:Complementary and Alternative Medicine Q1 16 / 105

85%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Complementary Therapies In Clinical Practice 中科院分区

中科院 2023年12月升级版 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 3区 INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学 3区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Complementary Therapies In Clinical Practice JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:INTEGRATIVE & COMPLEMENTARY MEDICINE SCIE Q2 17 / 43

61.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INTEGRATIVE & COMPLEMENTARY MEDICINE SCIE Q2 14 / 43

68.6%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计
  • 国家/地区数量
  • Iran83
  • USA76
  • CHINA MAINLAND65
  • Turkey58
  • Australia47
  • South Korea22
  • Brazil20
  • England17
  • Canada15
  • India14

本刊中国学者近年发表论文

  • 1、Additional health education and nutrition management cause more weight loss than concurrent training in overweight young females

    Author: Huang, Yaru; Dong, Xiaoqian; Xu, Liqian; Cao, Xiaona; Sun, Shengyan

    Journal: COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE. 2023; Vol. 51, Issue , pp. -. DOI: 10.1016/j.ctcp.2023.101721

  • 2、E-sports playing and its relation to lifestyle behaviors and psychological well-being: A large-scale study of collegiate e-sports players in China

    Author: Cheng, Miaoting; Chen, Lu; Pan, Qianqian; Gao, Yaying; Li, Jinming

    Journal: COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE. 2023; Vol. 51, Issue , pp. -. DOI: 10.1016/j.ctcp.2023.101731

  • 3、Efficacy and safety of Resina Draconis for wound repair in the treatment of diabetic foot ulcer: A systematic review and meta-analysis of randomized controlled trials

    Author: Feng, Haoyue; Huang, Wenhui; Zhou, Qi; Liu, Tianyi; Li, Hui; Yue, Rensong

    Journal: COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE. 2023; Vol. 50, Issue , pp. -. DOI: 10.1016/j.ctcp.2022.101707

  • 4、Association between sports participation and overall health in children and adolescents

    Author: Song, Yagang; Shi, Chongyan

    Journal: COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE. 2023; Vol. 51, Issue , pp. -. DOI: 10.1016/j.ctcp.2022.101718

  • 5、Efficacy and safety of Duhuo Jisheng decoction combined with Western medicine in the treatment of ankylosing spondylitis: A systematic review and meta-analysis

    Author: Wan, Renhong; Ji, Yue; Fan, Yihua; Yang, Chen; Yang, Hong; Gou, Xiaoping; Zhang, Xinyuan; Liu, Wei

    Journal: COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE. 2023; Vol. 51, Issue , pp. -. DOI: 10.1016/j.ctcp.2023.101739

  • 6、Effects of somatic acupoint stimulation on anxiety and depression in cancer patients: An updated systematic review of randomized controlled trials

    Author: Wang, Tao; Tan, Jing-Yu (Benjamin); Yao, Li-Qun; Cheng, Huilin; Zhao, Isabella; Eliseeva, Sabina; Polotan, Mary Janice

    Journal: COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE. 2023; Vol. 51, Issue , pp. -. DOI: 10.1016/j.ctcp.2023.101735

  • 7、Combinations of physical activity, screen time and sleep, and their association with subjective wellbeing in children

    Author: Sun, Jiangang; Jiang, Xiaoran; Wei, Shanshan

    Journal: COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE. 2023; Vol. 51, Issue , pp. -. DOI: 10.1016/j.ctcp.2023.101720

  • 8、Predicting academic performance associated with physical fitness of primary school students using machine learning methods

    Author: Xu, Keyun; Sun, Zhiyuan

    Journal: COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE. 2023; Vol. 51, Issue , pp. -. DOI: 10.1016/j.ctcp.2023.101736

投稿常见问题

通讯方式:THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB。